Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELATE and PREDICT TRD
NL-OMON38845Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of escitalopram and nortriptyline in major depressive disorder (MDD) and treatment-resistant depression (TRD) (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Change in HDRS-17 score, HDRS-17 response and 4 more. Started Nov 2014; status: active, not recruiting.
02
Drugs
escitalopramnortriptyline
03
Conditions
major depressive disorder (MDD)treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NL-OMON38845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38845.